Results 21 to 30 of about 22,409 (253)
Mutant Adenosine Deaminase 2 in a Polyarteritis Nodosa Vasculopathy
New England Journal of Medicine, 2014 BackgroundPolyarteritis nodosa is a systemic necrotizing vasculitis with a pathogenesis that is poorly understood. We identified six families with multiple cases of systemic and cutaneous polyarteritis nodosa, consistent with autosomal recessive ...
Elkan, PN;Pierce, SB;Segel, R;Walsh, T;Barash, J;Padeh, S;Zlotogorski, A;Berkun, Y;Press, JJ;Mukamel, M;Voth, I;Hashkes, PJ;Harel, L;Hoffer, V;Ling, E;Yalcinkaya, F;Kasapcopur, O;Lee, MK;Klevit, RE;Renbaum, P;Weinberg-Shukron, A;Sener, EF;Schormair, B;Zeligson, S;Marek-Yagel, D;Strom, TM;Shohat, M;Singer, A;Rubinow, A;Pras, E;Winkelmann, J;Tekin, M;Anikster, Y;King, MC;Levy-Lahad, E
core +3 more sources
Metabolic myopathy presenting with polyarteritis nodosa: a case report
Journal of Medical Case Reports, 2011 Introduction To the best of our knowledge, we describe for the first time a patient in whom an unusual metabolic myopathy was identified after failure to respond to curative therapy for a systemic vasculitis, polyarteritis nodosa.
Elbalkhi Amro +3 more
doaj +2 more sources
Arthritis & Rheumatology, 2021 To provide evidence‐based recommendations and expert guidance for the management of systemic polyarteritis nodosa (PAN).
Sharon A. Chung +31 more
semanticscholar +2 more sources
Iatreia, 2013 Vasculitis can be secondary to various processes, among them infections, malignancies, connective tissue diseases or medications, or primary, generally idiopathic.
Restrepo Escobar, Mauricio +2 more
doaj +1 more source
Polyarteritis Nodosa: Old Disease, New Etiologies
International Journal of Molecular Sciences, 2023 Polyarteritis nodosa (PAN), also known as panarteritis nodosa, represents a form of necrotizing vasculitis that predominantly affects medium-sized vessels, although it is not restricted to them and can also involve smaller vessels.
Louis Wolff +4 more
semanticscholar +1 more source
Modern Rheumatology Case Reports, 2022 The global outbreak of coronavirus disease (COVID-19) caused by severe acute respiratory syndrome coronavirus type 2 has prompted the rapid spread and development of vaccines to prevent the spread of the disease.
Y. Ohkubo +3 more
semanticscholar +1 more source
Arthritis & Rheumatology, 2021 Cyclophosphamide (CYC) is used in clinical practice off‐label for the induction of remission in childhood polyarteritis nodosa (PAN). Mycophenolate mofetil (MMF) might offer a less toxic alternative.
P. Brogan +22 more
semanticscholar +1 more source
Endovascular Biopsy of Vertebrobasilar Aneurysm in Patient With Polyarteritis Nodosa
Frontiers in Neurology, 2021 Background and Purpose: The management of unruptured intracranial aneurysms remains controversial. The decisions to treat are heavily informed by estimated risk of bleeding.
K. Narsinh +16 more
semanticscholar +1 more source
Oculomotor nerve palsy, an unusual onset of polyarteritis nodosa
, 2023 Introduction Cranial nerve involvement in polyarteritis nodosa(PAN) is underrecognized and rarely reported. The aim of this article is to review the available literature and present an example of oculomotor nerve palsy in the course of PAN. Material and
Filipe Oliveira Pinheiro +9 more
core +1 more source
Polyarteritis nodosa and deficiency of adenosine deaminase 2– shared genealogy, generations apart
Clinical Immunology, 2020 Polyarteritis nodosa (PAN) is a systemic necrotizing vasculitis that predominantly affects medium-sized arteries. With the establishment and refinement of vasculitis nomenclature and diagnostic criteria, clinical findings of PAN and distinguishing ...
Zhengping Huang +3 more
semanticscholar +1 more source